ACURATE Neo™ AS Aortic Bioprosthesis for Implantation Using the ACURATE neoTM AS TF Transfemoral Delivery System in Patients With Severe Aortic Stenosis

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

Also called NCT02909556

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Symetis SA (from the registry)
Registry
  • NCT NCT02909556
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Denmark, Germany, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02909556. Allocation not applicable; no masking; primary purpose treatment. Start 2016-12-16 (actual); primary completion 2018-01-24 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ACURATE Neo™ AS Aortic Bioprosthesis for Implantation Using the ACURATE neoTM AS TF Transfemoral Delivery System in Patients With Severe Aortic Stenosis
Condition
Aortic Stenosis
Lead sponsor
Symetis SA (class: industry)

Record details

Record id
cardio:ct-nct02909556
Content hash
5f4766e4645588c727daad3856e2e83054bc921b750c7d8a4f5f1474091c05e3